Abstract
This study is dedicated to a search for the association of the polymorphic markers T(−365)C of the POLG1 gene G(−25)A of the ANT1 gene and G(−605)T of the PEO1 gene with diabetic polyneuropathy (DPN) in Type 1 diabetes mellitus (DM1) patients. All patients were ethnic Russian Moscow residents, with DM1 records of no more than 5 years and DPN or DM1 records of more than 10 years but without DPN. We found that the polymorphic marker T(−365)C of POLG1 was associated with DPN in Russian patients with DM1. The carriers of the C allele and the CC genotype had a higher risk of DPN development (OR = 1.62; CI = 1.11–2.38; and OR = 1.76; CI = 0.99–3.13; respectively). In contrast, the T allele carrier status and the TT genotype were associated with a lower DPN risk (OR = 0.62, CI = 0.42–0.90; and OR = 0.61; CI = 0.35–1.07; respectively). We found no association of the polymorphic markers G(−25)A of ANT1 or G(−605)T of PEO1 with DPN in Russian DM1 patients living in Moscow.
Similar content being viewed by others
References
Boulton A.J. 2001. Treatments for diabetic neuropathy. Curr. Diab. Rep. 1, 127–132.
IDF Diabetes Atlas. Edition 2003. Available on http://www.eatlas.idf.org/Complications/Prevalence/index
Zotova, E.V., Chistyakov, D.A., Savost’yanov, K.V., Bursa T.R., Galeev I.V., Strokov I.A., Nosikov V.V. 2003. Association of the SOD2 Ala(−9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in diabetes mellitus type 1. Mol. Biol. 37, 345–348.
Zotova E.V., Savost’yanov K.V., Chistyakov D.A., Bursa T.R., Galeev I.V., Strokov I.A., Nosikov V.V. 2004. Association of polymorphic markers of the antioxidant enzyme genes with diabetic polyneuropathy in type 1 diabetes mellitus. Mol. Biol. 38, 244–249.
Stevens M.J., Obrosova I., Cao X., et al. 2000. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes. 49, 1006–1015.
Spitsina E.V., Yakunina N.Ya., Chudakova D.A., Nikitin A.G., Svetlova G.N., Soluyanova T.N., Strokov I.A., Nosikov V.V. 2007. The association of the TP53 polymorphisms Pro72Arg and C(−594)CC with diabetic polyneuropathy in Russian Muscovites with type 1 diabetes mellitus. Mol. Biol. 41, 989–993.
Kastan M.B., Onyekwere O., Sidransky D., et al. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304–6311.
Keim A.L., Chi M.M., Moley K.H. 2001. Hyperglycemia-induced apoptotic cell death in the mouse blastocystis dependent on expression of p53. Mol. Reprod. Dev. 60, 214–224.
Vincent A.M., Brownlee M., Russell J.W. 2002. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N.Y. Acad. Sci. 959, 368–383.
DiMauro S., Schon E.A. 2003. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348, 2656–2668.
van Houten B., Woshner V., Santos J.H. 2006. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair. 5, 145–152.
Hudson G., Chinnery P.F. 2006. Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 15, 244–252.
Zheng W., Khrapko K., Coller H., et al. 2006. Origins of human mitochondrial point mutations as DNA polymerase gamma-mediated errors. Mutat. Res. 599, 11–20.
Graziewicz M.A., Longley M.J. Copeland W.C. 2006. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem. Rev. 106, 383–405.
Lee W.S., Sokol R.J. 2007. Mitochondrial hepatopathies: Advances in genetics and pathogenesis. Hepatology. 45, 1555–1565.
Longley M.J., Ropp P.A., Lim S.E., et al. 1998. Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. Biochemistry. 37, 10529–10539.
Kaguni L.S. 2004. DNA polymerase gamma, the mitochondrial replicase. Annu. Rev. Biochem. 73, 293–320.
Longley M.J., Graziewicz M.A., Bienstock R.J., Copeland W.C. 2005. Consequences of mutations in human DNA polymerase gamma. Gene. 354, 125–131.
Luoma P.T., Eerola J., Ahola S., et al. 2007. Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology. 69, 1152–1159.
Tiangyou W., Hudson G., Ghezzi D., et al. 2006. POLG1 in idiopathic Parkinson disease. Neurology. 67, 1698–1700.
Ferrari G., Lamantea E., Donati A., et al. 2005. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gamma A. Brain. 128, 723–731.
Nguyen K.V., Ostergaard E., Ravn S.H., et al. 2005. POLG mutations in Alpers syndrome. Neurology. 65, 1493–1495.
van Goethem G., Martin J.J., Dermaut B., et al. 2003. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromusc. Disord. 13, 133–142.
Korhonen J.A., Gaspari M., Falkenberg M. 2003. TWINKLE has DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein. J. Biol. Chem. 278, 48627–48632.
Korhonen J.A., Pham X.H., Pellegrini M., et al. 2004. Reconstitution of a minimal mtDNA replisome in vitro. EMBO J. 23, 2423–2429.
Spelbrink J.N., Toivonen J.M., Hakkaart G.A., et al. 2000. In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J. Biol. Chem. 275, 24818–24828.
Tyynismaa H., Sembongi H., Bokori-Brown M., et al. 2004. Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. Hum. Mol. Genet. 13, 3219–3227.
Spelbrink J.N., Li F.-Y., Tiranti V., et al. 2001. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nature Genet. 28, 223–231.
Baloh R.H., Salavaggione E., Milbrandt J., et al. 2007. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch. Neurol. 64, 998–1000.
Kristal B.S., Matsuda M., Yu B.P. 1996. Abnormalities in the mitochondrial permeability transition in diabetic rats. Biochem. Biophys. Res. Commun. 222, 519–523.
Halestrap A.P., McStay G.P., Clarke S.J. 2002. The permeability transition pore complex: Another view. Biochimie. 84, 153–166.
Vyssokikh M.Y., Brdiczka D. 2003. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim. Pol. 50, 389–404.
Klingenberg M. 1985. The ADP/ATP carrier in mitochondrial membranes. In: The enzymes of Biological Membranes. N.Y.: Plenum Press, vol. 4, pp. 511–553.
Bottero V., Rossi F., Samson M., et al. 2001. Iκ b-α, the NF-κ B inhibitory subunit, interacts with ANT, the mitochondrial ATP/ADP translocator. J. Biol. Chem. 276, 21317–21324.
Belzacq A.S., Vieira H.L., Kroemer G., et al. 2002. The adenine nucleotide translocator in apoptosis. Biochimie. 84, 167–176.
Graham B.H., Waymire K.G., Cottrell B., et al. 1997. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genet. 16, 226–234.
Lodi T., Bove C., Fontanesi F., et al. 2006. Mutation D104G in ANT1 gene: Complementation study in Saccharomyces cerevisiae as a model system. Biochem. Biophys. Res. Commun. 341, 810–815.
Ziegler D., Hanefeld M., Ruhnau K.J., et al. 1995. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid: A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 38, 1425–1433.
Strokov I.A., Novosadova M.V., Barinov A.N., Yakhno N.N. 2000. Cliniocal methods for assessing the severity of diabetic polyneuropathy. Neurol. Zh. 5, 14–18.
Dyck P.J., Melton J.L., O’Brien P.C., Service F.G. 1997. Approaches to improve epidemiological studies of diabetic neuropathy: Insights from the Rochester Diabetic Neuropathy Study. Diabetes. 46, 5–8.
Komantsev V.N., Zabolotnykh V.A. 2001. Metodicheskie osnovy klinicheskoi elektroneiromiografii. Rukovodstvo dlya vrachei (Methodological Foundations of Clinical Electroneuromyography: A Manual for Doctors). St. Petersburg: Lan’.
Johns M.B., Paulus-Thomas J.E. 1989. Purification of human genomic DNA from whole blood using perchlorate in place of phenol. Anal. Biochem. 180, 276–278.
Hudson G., Chinnery P.F. 2006. Mitochondrial DNA polymerase-gamma and human disease. Hum. Mol. Genet. 15, 244–252.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.V. Spitsina, G.N. Svetlova, D.A. Chudakova, A.G. Nikitin, T.L. Kurayeva, I.A. Strokov, V.V. Nosikov, 2009, published in Molekulyarnaya Biologiya, 2009, Vol. 43, No. 2, pp. 378–382.
Rights and permissions
About this article
Cite this article
Spitsina, E.V., Svetlova, G.N., Chudakova, D.A. et al. Association of the POLG1 T(−365)C, ANT1 G(−25)A, and PEO1 G(−605)T polymorphisms with diabetic polyneuropathy in patients with Type 1 diabetes mellitus. Mol Biol 43, 348–352 (2009). https://doi.org/10.1134/S0026893309020186
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893309020186